Valuation: Orion Oyj

Market Cap 1.16TCr 1.31TCr 1.1TCr 994.64Cr 1.86TCr 1,26000Cr 1.88TCr 13TCr 5.07TCr 64TCr 4.93TCr 4.82TCr 2,07100Cr P/E 2026 *
20.5x
P/E 2027 * 17.4x
Enterprise Value 1.15TCr 1.3TCr 1.09TCr 986.93Cr 1.85TCr 1,25100Cr 1.87TCr 13TCr 5.03TCr 64TCr 4.89TCr 4.79TCr 2,05500Cr EV / Sales 2026 *
5.49x
EV / Sales 2027 * 4.74x
Free-Float
90.5%
Yield 2026 *
2.36%
Yield 2027 * 2.63%
1 day+11.24%
Current month+11.24%
1 month+11.24%
3 months+11.24%
6 months+16.59%
Current year+13.22%
1 month 92.05
Extreme 92.05
92.05
Current year 78.95
Extreme 78.95
92.05
1 year 78.95
Extreme 78.95
92.05
3 years 47.16
Extreme 47.16
92.05
5 years 37
Extreme 37
92.05
10 years 27.35
Extreme 27.35
92.05
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
+11.24%0.00% - - 1.31TCr
+0.05%+2.76%+55.01%+119.72% 1,05600Cr
-0.07%-0.39%+44.61%+72.82% 64TCr
+0.18%-0.41%+14.01%+78.07% 47TCr
-1.55%-0.72%+75.16%+43.35% 37TCr
-0.49%-4.05%+34.09%+40.50% 34TCr
-0.23%+2.55%+20.46%+29.16% 28TCr
-0.80%-0.87%+10.19%+12.53% 25TCr
-0.13%+4.33%+50.14%+59.10% 23TCr
-0.70%-0.64%+35.50%+102.97% 19TCr
Average +0.76%+0.12%+37.68%+62.02% 42.4TCr
Weighted average by Cap. -0.21%+0.30%+41.63%+74.24%

Financials

2026 *2027 *
Net sales 209.68Cr 237.6Cr 198.39Cr 179.92Cr 337.32Cr 23TCr 340.65Cr 2.38TCr 917.26Cr 12TCr 892.19Cr 872.78Cr 37TCr 237.31Cr 268.9Cr 224.53Cr 203.62Cr 381.76Cr 26TCr 385.53Cr 2.69TCr 1.04TCr 13TCr 1.01TCr 987.76Cr 42TCr
Net income 57Cr 64Cr 54Cr 49Cr 91Cr 6.15TCr 92Cr 641.96Cr 247.41Cr 3.14TCr 240.65Cr 235.42Cr 10TCr 67Cr 76Cr 63Cr 57Cr 107.46Cr 7.26TCr 108.52Cr 758.19Cr 292.21Cr 3.71TCr 284.22Cr 278.04Cr 12TCr
Net Debt -8.98Cr -10Cr -8.49Cr -7.7Cr -14Cr -975.98Cr -15Cr -101.88Cr -39Cr -498.38Cr -38Cr -37Cr -1.6TCr -33Cr -38Cr -32Cr -29Cr -54Cr -3.62TCr -54Cr -377.92Cr -145.65Cr -1.85TCr -141.67Cr -138.59Cr -5.95TCr
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
82.40EUR
Average target price
76.67EUR
Spread / Average Target
-6.96%

Quarterly revenue - Rate of surprise